Skip to main content
. Author manuscript; available in PMC: 2019 Nov 23.
Published in final edited form as: Ocul Surf. 2019 Feb 8;17(4):809–816. doi: 10.1016/j.jtos.2019.02.003

Fig. 6.

Fig. 6.

Western blot of CK5. (A) Representative image showing downregulation of CK5 in cells treated with rosiglitazone. (B) Bar graph obtained from 4 independent experiments. Rosiglitazone significantly downregulated expression of CK5 in hMGECs after both 1d and 3d treatment (*: P < 0.05).